Trials / Recruiting
RecruitingNCT04008329
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- First Affiliated Hospital of Fujian Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.
Detailed description
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND), which is characterized with highly clinical heterogeneity and no effective treatment is available now. The purpose of this registered cohort is to observe the natural history of ALS patients in China, and then identify some factors correlated with disease progression. Besides, ALS-related gene mutations will be screened and explore novel disease causing gene as well.
Conditions
Timeline
- Start date
- 2019-07-05
- Primary completion
- 2029-07-01
- Completion
- 2059-07-01
- First posted
- 2019-07-05
- Last updated
- 2021-03-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04008329. Inclusion in this directory is not an endorsement.